SYNERGY(SZ:300636)2025-04-27 09:20Financial Performance Overview - In 2024, the company achieved sales revenue of ¥758.89 million, a year-on-year increase of 5.09% [2] - Net profit for 2024 was ¥106.58 million, a slight increase of 0.57% year-on-year [2] - Gross margin was 33.01%, down by 0.29 percentage points compared to the previous year [2] - Net margin was 14.04%, down by 0.63 percentage points year-on-year [2] - For Q1 2025, sales revenue was ¥186.90 million, a decrease of 9.47% year-on-year [2] - Q1 2025 net profit was ¥20.78 million, down 52.30% year-on-year [2] Business Segment Performance CMO/CDMO Business - In 2024, CMO/CDMO revenue was ¥82.69 million, a decline of 43.18% year-on-year [6] - Q1 2025 CMO/CDMO revenue was ¥4.94 million, down 85.32% year-on-year [6] New Products - New product sales in 2024 reached ¥361.68 million, a growth of 17.38% year-on-year [6] - Q1 2025 new product sales were ¥80.64 million, a decrease of 26.50% year-on-year [6] Domestic Sales - Domestic sales in 2024 were ¥144.87 million, a decline of 1.46% year-on-year [3] - Q1 2025 domestic sales were ¥35.70 million, an increase of 4.68% year-on-year [2] Market Trends and Challenges - The company faces increased competition and price declines in mature products due to expanded domestic and international capacities [7] - The CMO/CDMO segment is under pressure from recent policy changes affecting international projects [6] - The domestic market is experiencing price drops due to centralized procurement and reduced demand [5] Future Outlook - The company plans to continue focusing on new product development and maintaining high R&D investment levels [7] - Expected sales for new raw materials in the regulatory market are projected at ¥180 million for 2024 and ¥230 million for 2025 [8] - The second phase of the new plant is expected to contribute significantly to production capacity by 2026 [9]